UK markets open in 44 minutes

ImmuPharma plc (IMM.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
2.1250-0.0200 (-0.93%)
At close: 04:19PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
94.819
118.35
126.667
77.925
Operating expenses
Research development
3,638
3,650
2,373
2,665
Selling general and administrative
653.482
1,011
1,765
1,831
Total operating expenses
4,691
5,278
5,716
6,360
Operating income or loss
-4,596
-5,160
-5,589
-6,282
Interest expense
-603.821
124.063
230.828
4.045
Income before tax
-6,881
-8,941
-7,246
-6,744
Income tax expense
-702.919
-766.814
-386.248
-620.774
Income from continuing operations
-6,178
-8,174
-6,860
-6,124
Net income
-6,178
-8,174
-6,860
-6,124
Net income available to common shareholders
-6,178
-8,174
-6,860
-6,124
Basic EPS
-
-0.03
-0.03
-0.04
Diluted EPS
-
-0.03
-0.03
-0.04
Basic average shares
-
251,164
200,176
153,452
Diluted average shares
-
251,164
200,176
153,452
EBITDA
-
-8,703
-6,844
-6,652